Spring Bank Pharmaceuticals replaces chairman; director steps down
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Spring Bank Pharmaceuticals Inc. named Scott Smith to be the company's chairman, effective Jan. 1, 2019.
Smith will replace Martin Driscoll, who will continue as the company's president and CEO.
Meanwhile, Christiana Bardon stepped down as a director of the U.S.-based clinical-stage biopharmaceutical company.
